PRO-MERIT (Prostate Cancer Messenger RNA Immunotherapy)

Clinical trial NCT04382898 · TERMINATED

Trial details

NCT number: NCT04382898
Sponsor: BioNTech SE
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2019-12-19
Primary completion: 2024-01-23
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.